| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.092 | 0.09 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.097 | 0.09 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |